LIU Shan,HU Meng,ZHANG Zhuo,et al.The in vitro and in vivo inhibitory effects of metformin on esophageal squamous cell carcinoma cells[J].ZHONGGUO YAOFANG,2025,36(17):2113-2119.
LIU Shan,HU Meng,ZHANG Zhuo,et al.The in vitro and in vivo inhibitory effects of metformin on esophageal squamous cell carcinoma cells[J].ZHONGGUO YAOFANG,2025,36(17):2113-2119. DOI: 10.6039/j.issn.1001-0408.2025.17.06.
The in vitro and in vivo inhibitory effects of metformin on esophageal squamous cell carcinoma cells
inhibitory effects and mechanism of metformin on the malignant biological behavior of esophageal squamous cell carcinoma (ESCC) cells by the hypoxia inducible factor-1α (HIF-1α)/interleukin-8 (IL-8) signaling pathway.
METHODS
2
Human ESCC TE1 cells were assigned into blank group, metformin low-, medium-, and high-dose groups (0.5, 1, 2 mmol/L), IDF-11774 (HIF-1α inhibitor) group (20 μmol/L), and high-dose metformin+HIF-1α activator dimethyloxalylglycine (DMOG) group. After 24 h treatment, cell proliferation [measured by the positive rate of 5-ethynyl-2′-deoxyuridine (EdU) and optical density at 450 nm (OD
450
value)
]
, apoptosis, invasion and migration as well as mRNA expressions of proliferating cell nuclear antigen (PCNA), Bcl-2 interacting mediator of cell death (Bim), migration and invasion enhancer 1 (MIEN1), and matrix metalloproteinase-9 (MMP-9), and protein expressions of HIF-1α and IL-8 in the cells were detected. The xenograft tumor model of nude mice was established. Thirty nude mice were randomly divided into blank group, metformin low-, medium-, and high-dose groups (i.g. administration of metformin 62.5, 125, 250 mg/kg+i.p. administration of equal volume of normal saline), IDF-11774 group (i.g. administration of 50 mg/kg IDF-11774+i.p. administration of equal volume of normal saline) and high-dose metformin+DMOG group (i.g. administration of metformin 250 mg/kg+i.p. administration of DMOG 250 mg/kg), with 5 mice in each group. They were given relevant medicine, once a day, for 4 consecutive weeks; the mass and volume of the tumor and
protein expressions of HIF-1α and IL-8 in the tumor tissue were determined.
RESULTS
2
The EdU positive rate, OD
450
value, cell invasion number, scratch healing rate, mRNA expressions of PCNA, MIEN1 and MMP-9, protein expressions of HIF-1α and IL-8, as well as the mass and volume of transplanted tumors and protein expressions of HIF-1α and IL-8 in tumor tissues were decreased by metformin in concentration/dose-dependent manner (
P
<0.05). Additionally, metformin increased the apoptosis rate and mRNA expression of Bim in cells (
P
<0.05). The trend of changes in corresponding indicators in the IDF-11774 group was consistent with that in the metformin groups, whereas DMOG could significantly attenuate the aforementioned effects of high-concentration/high-dose metformin (
P
<0.05).
CONCLUSIONS
2
Metformin can inhibit the proliferation, invasion, migration of TE1 cells, and tumor growth of nude mice, and induce cell apoptosis, the mechanism of which may be related to the inhibition of HIF-1α/IL-8 signaling pathway.
关键词
Keywords
references
LIANG H P , CHE W B , PENG F Y , et al . Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR-153-3p/SATB1 signaling pathway [J ] . Thorac Cancer , 2024 , 15 ( 7 ): 538 - 549 .
SONG D , YE Z Q , CHEN F Y , et al . circFNDC3B promotes esophageal squamous cell carcinoma progression by targeting MYO5A via miR-370-3p/miR-136-5p [J ] . BMC Cancer , 2023 , 23 ( 1 ): 821 .
TAN Z R , LUAN S J , WANG X P , et al . Mechanism study of lncRNA RMRP regulating esophageal squamous cell carcinoma through miR-580-3p/ATP13A3 axis [J ] . Discov Oncol , 2024 , 15 ( 1 ): 150 .
LI J H , HSIN P Y , HSIAO Y C , et al . A narrative review:repurposing metformin as a potential therapeutic agent for oral cancer [J ] . Cancers (Basel) , 2024 , 16 ( 17 ): 3017 .
SONG S , ZHANG Y H , DUAN X C , et al . HIF-1α/IL-8 axis in hypoxic macrophages promotes esophageal cancer progression by enhancing PD-L1 expression [J ] . Cancer Gene Ther , 2023 , 30 ( 2 ): 358 - 367 .
BAN H S , KIM B K , LEE H , et al . The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism,thereby suppressing tumor growth [J ] . Cell Death Dis , 2017 , 8 ( 6 ): e2843 .
HE J , QIN Z S , CHEN X , et al . HIF-1α ameliorates diabetic neuropathic pain via parkin-mediated mitophagy in a mouse model [J ] . Biomed Res Int , 2022 , 2022 : 5274375 .
YUAN Q , SHI Y S , ZHANG Y H , et al . Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma [J ] . Cancer Cell Int , 2024 , 24 ( 1 ): 114 .
JU Q Q , SHI Q Y , LIU C , et al . Bufalin suppresses esophageal squamous cell carcinoma progression by activating the PIAS3/STAT3 signaling pathway [J ] . J Thorac Dis , 2023 , 15 ( 4 ): 2141 - 2160 .
LIN H , AO H Y , GUO G H , et al . The role and mechanism of metformin in inflammatory diseases [J ] . J Inflamm Res , 2023 , 16 : 5545 - 5564 .
SUGIMOTO Y , OKAMOTO K , SAITO H , et al . Metformin suppresses esophageal cancer progression through the radiation-induced cellular senescence of cancer-associated fibroblasts [J ] . Oncol Rep , 2024 , 52 ( 4 ): 129 .
XIAO Q , XIAO J N , LIU J Q , et al . Metformin suppresses the growth of colorectal cancer by targeting INHBA to inhibit TGF-β/PI3K/AKT signaling transduction [J ] . Cell Death Dis , 2022 , 13 ( 3 ): 202 .
CHEN R , CHEN J H , CHEN M L , et al . Metformin suppresses proliferation and glycolysis of gastric cancer by modulating ADAMTS12 [J ] . Genes Environ , 2024 , 46 ( 1 ): 1 .
MAGRINO J , MUNFORD V , MARTINS D J , et al . A thermosensitive PCNA allele underlies an ataxia-telangiectasia-like disorder [J ] . J Biol Chem , 2023 , 299 ( 5 ): 104656 .
TRIPATHI A K , DESAI P P , TYAGI A , et al . Short peptides based on the conserved regions of MIEN1 protein exhibit anticancer activity by targeting the MIEN1 signaling pathway [J ] . J Biol Chem , 2024 , 300 ( 3 ): 105680 .
SHI H M , KONG R Y , MIAO X , et al . Decreased PPP1R3G in pre-eclampsia impairs human trophoblast invasion and migration via Akt/MMP-9 signaling pathway [J ] . Exp Biol Med (Maywood) , 2023 , 248 ( 16 ): 1373 - 1382 .
FENG Y , LI T J , LI Y , et al . Glutaredoxin-1 promotes lymphangioleiomyomatosis progression through inhibi- ting Bim-mediated apoptosis via COX2/PGE2/ERK pathway [J ] . Clin Transl Med , 2023 , 13 ( 7 ): e1333 .
FEI M Y , GUAN J M , XUE T , et al . Hypoxia promotes the migration and invasion of human hepatocarcinoma cells through the HIF-1α-IL-8-Akt axis [J ] . Cell Mol Biol Lett , 2018 , 23 : 46 .